Abstract Body

The interplay between intestinal epithelial cells (IEC) and Th17 cells is key for mucosal immunity homeostasis. HIV infection provokes intestinal barrier function impairment and chronic immune activation, which are not normalized by antiretroviral therapy (ART). Such alterations coincide with the overexpression of IL-32, a newly described cytokine, with multiple isoforms. IL-32 overexpression was predictive of the loss of viral control in HIV slow progressors and associated with non-AIDS co-morbidities such as cardiovascular disease (CVD). The role of specific IL-32 isoforms in HIV pathogenesis remains poorly investigated. Here, we quantified the expression of IL-32 isoforms in the colon and blood of ART-treated people living with HIV (ART+PLWH), and explored the regulation of IL-32 expression by the Th17 hallmark cytokine IL-17A.

Matched PBMC and sigmoid colon biopsies were available from n=17 ART+PLWH (median age: 55 years; CD4 counts: 679 cells/ul; time on ART: 72 months) and n=5 age-matched HIV-uninfected controls. The HT-29 IEC line was used to study the modulation of IL-32 expression upon exposure to recombinant TNF-α and/or IL-17A, the TLR-3 agonist Poly:IC, or the HIV NL4.3BaL or THRO strains. IL-32α, β, γ, d, ε, t mRNA expression was measured by real-time RT-PCR. IL-32 protein production was measured in cell-culture supernatant and cell lysates by ELISA.

Our results reveal a significant increase in IL-32 mRNA expression, specifically IL-32β and ε, in colon biopsies and PBMC of ART+PLWH compared to uninfected controls. IL-32 mRNA expression, especially IL-32β, γ and ε, was induced by exposure of HT-29 cells to recombinant TNF-α, Poly:IC and HIV THRO strain. IL-32 mRNA levels positively correlated with intracellular IL-32 protein expression, but no soluble IL-32 was detected in cell culture supernatants, indicative that IL-32 protein expression in IEC is mainly intracellular. Of note, recombinant IL-17A significantly decreased IL-32 mRNA/protein expression induced by TNF-α and Poly:IC, supporting an immune-regulatory role played by IL-17A.

Our results document the overexpression of specific IL-32 isoforms in colon biopsies and PBMC of ART-treated PLWH and point to the negative consequences of mucosal Th17 paucity, in line with our discovery that IL-17A acts as a negative regulator of IL-32 isoforms with pro-inflammatory and/or antiviral features.